Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3851/IMP3261 | DOI Listing |
Publication Analysis
Top Keywords
correction daring-b
4
daring-b discontinuation
4
discontinuation effective
4
effective entecavir
4
entecavir tenofovir
4
tenofovir disoproxil
4
disoproxil fumarate
4
fumarate long-term
4
long-term therapy
4
therapy hbsag
4
Similar Publications
Correction: DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B.
Antivir Ther
January 2018
Department of Medicine and Research Laboratory of Internal Medicine, Thessaly University Medical School, Larissa, Greece.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!